|
Market Closed -
Other stock markets
|
After hours 14:17:44 | |||
| 49.49 EUR | -0.78% |
|
49.38 | -0.21% |
| 06-09 | AlphaValue/Baader Europe Updates Fresenius Medical Rating; EPS Estimates Upgraded | MT |
| 06-06 | DAX Index Edges Down Amid Downbeat German Trade, Industrial Data | MT |
| Capitalization | 14.64B 16.92B 13.73B 12.44B 22.98B 1,457B 25.99B 161B 62.45B 667B 63.5B 62.13B 2,436B | P/E ratio 2025 * |
15.9x | P/E ratio 2026 * | 12.6x |
|---|---|---|---|---|---|
| Enterprise value | 24.13B 27.89B 22.64B 20.51B 37.87B 2,401B 42.84B 265B 103B 1,099B 105B 102B 4,015B | EV / Sales 2025 * |
1.23x | EV / Sales 2026 * | 1.14x |
| Free-Float |
67.83% | Yield 2025 * |
2.98% | Yield 2026 * | 3.39% |
More valuation ratios
* Estimated data
More news
Last Transcript: Fresenius Medical Care AG
More recommendations
More press releases
More news
| 1 day | +0.19% | ||
| 1 week | -0.26% | ||
| Current month | -0.10% | ||
| 1 month | -2.78% | ||
| 3 months | +13.39% | ||
| 6 months | +9.58% | ||
| Current year | +13.16% |
| 1 week | 49.2 |  | 50.76 |
| 1 month | 49.2 | | 54.02 |
| Current year | 39.43 | | 54.02 |
| 1 year | 32.51 | | 54.02 |
| 3 years | 25.95 | | 54.02 |
| 5 years | 25.95 | | 79.96 |
| 10 years | 25.95 | | 93.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 57 | 2022-12-05 |
Martin Fischer
DFI | Director of Finance/CFO | 48 | 2023-09-30 |
Jörg Häring
CMP | Compliance Officer | 55 | 2024-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 58 | 2016-05-11 |
A. Sorensen
BRD | Director/Board Member | 63 | 2021-05-19 |
Michael Sen
CHM | Chairman | 56 | 2023-07-13 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 7.48% | 0 M€ | -.--% | - | |
| 0.8% | 0 M€ | -.--% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.26% | -0.26% | +34.40% | +0.14% | 16.92B | ||
| -0.13% | -3.42% | +9.99% | +104.29% | 89.3B | ||
| +1.67% | +6.10% | +12.02% | -26.23% | 85.34B | ||
| +0.48% | +0.55% | +50.24% | +51.73% | 28.65B | ||
| -1.15% | -0.39% | -14.20% | +26.42% | 24.34B | ||
| -0.20% | +2.82% | +30.64% | +19.25% | 21.86B | ||
| +0.65% | +3.37% | +30.73% | +39.94% | 20.12B | ||
| -0.71% | -4.14% | +19.10% | +202.93% | 15.27B | ||
| -0.43% | -2.06% | +30.34% | +10.73% | 13.99B | ||
| +0.76% | +4.15% | +37.82% | +254.30% | 13.92B | ||
| Average | +0.10% | +0.67% | +24.11% | +68.35% | 32.97B | |
| Weighted average by Cap. | +0.36% | +0.90% | +18.57% | +52.22% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 19.66B 22.73B 18.45B 16.72B 30.87B 1,957B 34.92B 216B 83.92B 896B 85.32B 83.48B 3,273B | 20.35B 23.52B 19.09B 17.3B 31.94B 2,025B 36.13B 223B 86.82B 927B 88.28B 86.37B 3,386B |
| Net income | 920M 1.06B 864M 783M 1.44B 91.6B 1.63B 10.09B 3.93B 41.94B 3.99B 3.91B 153B | 1.15B 1.33B 1.08B 981M 1.81B 115B 2.05B 12.65B 4.92B 52.57B 5.01B 4.9B 192B |
| Net Debt | 9.49B 10.97B 8.9B 8.07B 14.9B 944B 16.85B 104B 40.5B 432B 41.17B 40.29B 1,579B | 8.53B 9.86B 8B 7.25B 13.39B 849B 15.14B 93.53B 36.39B 389B 37B 36.2B 1,419B |
More financial data
* Estimated data
Employees
112,035
Calendar
06-17
- Capital Markets Day
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-16 | 49.49 € | -0.78% | 476,857 |
| 25-06-13 | 49.88 € | +0.02% | 403,061 |
| 25-06-12 | 49.87 € | +0.65% | 461,020 |
| 25-06-11 | 49.55 € | -1.14% | 436,691 |
| 25-06-10 | 50.12 € | +0.04% | 430,924 |
Delayed Quote Xetra, June 16, 2025 at 03:33 am
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
49.88EUR
Average target price
50.06EUR
Spread / Average Target
+0.36%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- FME Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition